Direct answer: the metrics that matter most
Clinics should track prior authorization workflow metrics as operational measures, not as a single efficiency score. The most useful measures are submission-to-decision time, payer response time, first-pass approval rate, denial rate, overturn rate, manual-touch rate, escalation age, and authorization-related patient abandonment. A clinic that reports only the percentage of requests approved can look healthy while patients wait weeks, staff repeatedly rebuild incomplete cases, or denials are overturned only after expensive appeals. For care networks, the same measures should be segmented by payer, service line, facility, request type, and urgency. GetPulse.care’s B2B care-coordination approach treats prior authorization as a patient-pulse and revenue-cycle workflow: the goal is to connect operational delay with patient access, staff workload, and financial exposure. In 2026, measurement should include both cycle-time performance and the quality of each decision, because speed without accuracy creates rework. A useful dashboard therefore answers four questions: how long does authorization take, where does it stall, who must intervene, and what happens to the patient while the process continues.
Also worth reading: What are prior authorization reversal codes and how do they work in healthcare revenue cycle management? · How do I build a prior authorization ROI calculator for 2026 operations? · What is the ROI of clinic prior authorization automation?
Why prior authorization metrics need better measurement
Prior authorization is often described as a binary process: a request is approved or denied. Real workflows are less tidy. A request may be returned for missing documentation, assigned to several queues, paused during a payer holiday, escalated to a specialist, or approved for a narrower code than the one originally submitted. The KFF discussion of prior authorization metrics emphasizes that available data can reveal differences among insurers but still leaves important gaps. That is a useful warning for clinics. A metric may be precise about an event, such as the date an authorization was approved, while telling little about the work required to obtain that approval. The American Medical Association has separately raised concerns about CMS policies and administrative burdens, while Health Affairs has examined proposed CMS rules affecting prior authorization for drugs. These sources point in the same direction: policy and technology changes do not automatically produce a better workflow. They create new exceptions, documentation requirements, and reporting demands that clinics must measure locally.
The underlying problem is that prior authorization crosses organizational boundaries. A front-desk employee may initiate the request, a coder may select the code, a clinician may supply records, a utilization-review nurse may answer a payer question, and a financial-clearance team may track the expiration date. If each team records only its own task, the clinic cannot reconstruct the full elapsed time or identify the constraint causing delay. A patient-pulse system should capture timestamps at submission, receipt, clarification request, escalation, decision, and notification. It should also record whether the request was electronic, fax-based, portal-based, or handled by a vendor. This does not mean every workflow must be automated. It means the clinic should know which workflows exist before deciding where automation is safe.
Recommended metric definitions and operational thresholds
Metric definitions must be written down before a dashboard is built, because teams frequently use the same label for different events. “Days to decision” should specify whether it begins at order creation, clinical documentation, payer receipt, or first complete submission. “Response time” should separate payer questions from clinical review, and “cycle time” should include rework. A practical starting target for routine, nonurgent authorizations is a median of 7 business days or fewer, with a 90th percentile of 14 business days or fewer; these are management benchmarks, not universal legal standards. Urgent requests should be monitored against payer and plan-specific deadlines rather than a single clinic-wide target. A first-pass approval rate below 85% is a reasonable investigation trigger for a mature process, while a rate below 70% suggests a systematic coding, documentation, or submission problem. These thresholds should be adjusted after 90 to 180 days of baseline measurement.
| Feature | Clinic-operated baseline workflow | Network-wide managed workflow |
|---|---|---|
| Primary focus | Individual request status and staff follow-up | Comparative performance across sites, payers, and service lines |
| Typical cycle-time reporting | Manual spreadsheet or EHR task list | Automated timestamps with alerting and drill-down |
| Segmentation | Limited, often by facility or request type | Payer, provider, CPT or revenue code, urgency, and submission channel |
| Improvement measurement | Before-and-after staff estimates | Cohort comparison with median, 90th percentile, and trend reporting |
| Best use | Small practices with simple payer mix | Regional clinics and care networks managing volume and variation |
| Main limitation | Low reporting consistency and weak historical context | Higher implementation cost, data mapping, and governance requirements |
How to build a practical prior authorization dashboard
Start by defining a small set of events rather than attempting to measure every possible status. The minimum event set includes authorization created, clinical information complete, request submitted, payer acknowledged, clarification requested, clarification submitted, escalation opened, decision received, appeal filed, appeal resolved, and patient or appointment notified. Each event needs a timestamp, source, user or role, and reason code. Reason codes should distinguish missing documentation, incorrect code, wrong site, benefit issue, clinical necessity question, payer system error, and duplicate request. Without reason codes, a clinic may know that a request bounced but not whether the cause is clinical, administrative, or technical. The system should retain the original submission and every resubmission so rework can be counted accurately.
Next, connect authorization performance to patient-pulse measures. For scheduled procedures, track days between request creation and the scheduled service date, the percentage of appointments delayed because authorization was unresolved, and the percentage of patients who received a proactive status update. For medications, track abandonment after a denial or pending request, time to pharmacy-ready status, and the number of calls required to obtain a decision. A clinic may discover that median authorization time is eight days, but 19% of patients still miss their appointment because a particular payer’s response arrives after the facility’s scheduling cutoff. That is a more actionable finding than a generic statement that prior authorization takes too long. In a B2B care-coordination platform, these connections help managers decide whether the next intervention belongs in scheduling, clinical documentation, payer escalation, or patient communication.
Use cohort comparisons instead of judging every month in isolation. Compare the same payer, CPT or revenue code, urgency level, and submission method over time. A 12-month rolling view is often more reliable than a weekly snapshot, while weekly alerts are useful for cases approaching an escalation threshold. Reports should show counts as well as percentages. A 70% approval rate based on 20 requests is materially different from a 70% rate based on 2,000 requests. Managers should also see the 50th, 75th, and 90th percentiles for cycle time because distributions reveal operational inconsistency. A useful service-level objective might be that 90% of routine requests receive a decision within 10 business days, but the objective should be tested against the clinic’s own baseline and contractual requirements rather than presented as an industry requirement.
Where automation helps, and where oversight remains necessary
Automation is well suited to repetitive work: checking whether required fields are present, routing a request to the correct queue, reminding staff when a payer has not acknowledged it, detecting an approaching expiration date, and generating a status message for a patient or referring provider. It can also identify patterns such as a payer repeatedly requesting the same attachment or a facility using the wrong authorization form. Those applications reduce clerical load and make delays more visible. They do not remove the need for clinical judgment. AI-assisted review of medical necessity or code selection can create inconsistent decisions, expose protected information, or produce an explanation that a reviewer cannot defend. FTI Consulting’s work on AI in prior authorization decisions emphasizes the need for advanced oversight, and the research context makes the same point: testing operations is not the same as proving clinical accuracy.
A controlled rollout should begin with low-risk functions and retain human approval at consequential steps. For example, automation can flag missing fields, but a trained employee should confirm that the submitted record actually supports the request. Automated denial or escalation recommendations should be sampled by a utilization-review specialist, and every override should be logged. A reasonable monitoring plan is to review 5% of automated decisions for the first month, then 2% to 5% monthly once performance stabilizes, with all adverse or high-dollar cases reviewed. The clinic should track false-positive and false-negative indicators, override rate, and the percentage of decisions that required correction. It should also verify that the tool’s rules reflect current payer requirements, since a policy change can make a previously valid workflow invalid. Technology can expose a broken process; it cannot compensate for an unclear process.
Common measurement mistakes and how to avoid them
The first mistake is treating authorization as a purely financial event. A request may be approved but arrive after the patient has changed treatment plans, filled a prescription elsewhere, or canceled an appointment. The second is averaging across payers and service lines. A single overall turnaround time can hide a 30-day outlier from one payer or a recurring problem with one high-volume code. The third is counting approval as success without recording scope, duration, or conditions. An approval for a different code, a shorter treatment period, or a different site may require additional work. The fourth is measuring only completed requests, which makes severe backlog cases invisible. The fifth is assuming that electronic submission automatically reduces total cycle time; electronic channels can produce faster acknowledgment while still requiring repeated manual corrections.
Teams should document exclusions and missing data instead of silently dropping difficult cases from the denominator. If an external vendor handles authorizations, the clinic needs timestamps for both vendor receipt and payer decision, not merely a monthly status export. If a request is urgent, it should be reported in an urgent cohort, although urgent volumes may be too small for stable percentages. A dashboard should distinguish no decision yet from no authorization required and from authorization denied. It should also record the observation date, because a request pending for two days is different from one pending for two months. A data-quality owner should review completeness weekly during implementation and monthly afterward. When a metric changes, managers should be able to see whether the change came from real performance, a revised definition, a new payer rule, or missing records.
When to act, escalate, and reconsider the workflow
Escalation should be triggered by age, risk, and patient consequence rather than by a single universal number. A reasonable initial framework is to review routine requests at 5 business days, escalate at 8 business days, and escalate immediately when a scheduled procedure is within 10 business days or a medication has an imminent clinical need. These are operating suggestions, not substitute instructions for a payer’s own urgent-appeal rules. The clinic should maintain a clear owner for each escalation, a documented next action, and a response deadline. An escalation without an owner and next action is only a notification. If a request reaches 20 business days, the manager should perform a formal case review, determine whether the request is still necessary, and consider whether the patient needs an alternative plan. This is why patient-pulse data matters: a delayed authorization is an operational event, but it can also become an access event.
Reconsidering the workflow is appropriate when a payer’s median exceeds 14 business days for three consecutive months, when first-pass approval falls below 70%, or when more than 20% of cases require the same clarification. Recalibration may mean changing the submission channel, revising the documentation packet, renegotiating a payer process, adding a utilization-review specialist, or redesigning the EHR work queue. Before adding staff or software, quantify the volume behind the problem. A clinic handling 300 routine requests per month with a 10% rework rate has a different issue from one handling 30 urgent requests with a 40% denial rate. The remedy should follow the evidence. A phased 90-day improvement cycle—baseline measurement, one targeted change, and controlled comparison—is usually more defensible than a broad platform purchase presented as an instant fix. CMS-0057-F and related policy activity may create new operational requirements, so a system built around dated assumptions should be revisited at least annually.
What clinics and care networks should pay for
Pricing for prior authorization software depends on whether the product is a standalone queue, an EHR integration, a vendor-management layer, or a broader care-coordination platform. Small clinics may encounter monthly subscriptions in the hundreds of dollars, while enterprise deployments can reach tens of thousands of dollars annually before implementation, interface, and support charges; these are broad market ranges, not quoted prices for GetPulse.care. Implementation may include data migration, payer-rule configuration, staff training, and security review, so the total cost can exceed the license fee. Buyers should ask whether pricing is based on providers, authorizations, facilities, payers, users, or transaction volume. A low per-user price can become expensive if every employee needs separate access, while a low per-request price may be unattractive to a network with high volume.
Evaluate cost against measurable reduction in rework, staff minutes, denial appeals, and patient notification failures. A platform that saves 20 administrative hours per month has a different value proposition from one that merely displays a list of pending requests, even if both have similar dashboards. Request a pilot with defined baseline metrics, a 60- to 90-day evaluation period, and a written data-export plan. Confirm whether the vendor supports CMS interoperability expectations, role-based access, audit logs, retention controls, and reporting by payer and service line. Do not treat an AI feature as a substitute for a defensible appeal process or clinical review. The best purchase decision is not the product with the most automation; it is the one that produces reliable operational information, supports timely human decisions, and helps the organization learn which workflows actually need to change.